Jon K. Hayashida's most recent trade in Staar Surgical Co. was a trade of 10,760 Common Stock done at an average price of $124.1 . Disclosure was reported to the exchange on May 10, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Sale of securities on an exchange or to another person at price $ 124.13 per share. | 10 May 2021 | 10,760 | 16,301 (0%) | 0% | 124.1 | 1,335,639 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.15 per share. | 10 May 2021 | 7,200 | 15,542 (0%) | 0% | 16.2 | 116,280 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 7,200 | 0 | - | - | Common Stock Options | |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.53 per share. | 10 May 2021 | 5,523 | 27,061 (0%) | 0% | 27.5 | 152,048 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 5,523 | 9,774 | - | - | Common Stock Options | |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.98 per share. | 10 May 2021 | 3,462 | 21,538 (0%) | 0% | 36.0 | 124,563 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 3,462 | 8,564 | - | - | Common Stock Options | |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.80 per share. | 10 May 2021 | 2,534 | 18,076 (0%) | 0% | 29.8 | 75,513 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 2,534 | 750 | - | - | Common Stock Options | |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Sale of securities on an exchange or to another person at price $ 125.22 per share. | 10 May 2021 | 1,349 | 8,342 (0%) | 0% | 125.2 | 168,922 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Sale of securities on an exchange or to another person at price $ 96.37 per share. | 22 Mar 2021 | 1,103 | 9,691 (0%) | 0% | 96.4 | 106,296 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 9,759 | 9,759 | - | - | Common Stock Options | |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Sale of securities on an exchange or to another person at price $ 105.43 per share. | 01 Mar 2021 | 16,000 | 10,794 (0%) | 0% | 105.4 | 1,686,880 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 16,000 | 12,026 | - | - | Common Stock Options | |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.98 per share. | 01 Mar 2021 | 16,000 | 26,794 (0%) | 0% | 36.0 | 575,680 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Sale of securities on an exchange or to another person at price $ 81.34 per share. | 09 Nov 2020 | 20,000 | 10,794 (0%) | 0% | 81.3 | 1,626,800 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.80 per share. | 09 Nov 2020 | 10,200 | 20,994 (0%) | 0% | 29.8 | 303,960 | Common Stock |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 10,200 | 1,058 | - | - | Common Stock Options | |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 9,800 | 724 | - | - | Common Stock Options | |
| Staar Surgical Co. | Jon K. Hayashida | VP, Global Clinical, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.15 per share. | 09 Nov 2020 | 9,800 | 30,794 (0%) | 0% | 16.2 | 158,270 | Common Stock |